and cyclic nucleotide-gated (HCN) channels mediate the I h current in the murine hippocampus. Disruption of the I h current by knockout of HCN1, HCN2 or tetratricopeptide repeat-containing Rab8b-interacting protein has been shown to affect physiological processes such as synaptic integration and maintenance of resting membrane potentials as well as several behaviors in mice, including depressive-like and anxiety-like behaviors. However, the potential involvement of the HCN4 isoform in these processes is unknown. Here, we assessed the contribution of the HCN4 isoform to neuronal processing and hippocampus-based behaviors in mice. We show that HCN4 is expressed in various regions of the hippocampus, with distinct expression patterns that partially overlapped with other HCN isoforms. For behavioral analysis, we specifically modulated HCN4 expression by injecting recombinant adeno-associated viral (rAAV) vectors mediating expression of short hairpin RNA against hcn4 (shHcn4) into the dorsal hippocampus of mice. HCN4 knockdown produced no effect on contextual fear conditioning or spatial memory. However, a pronounced anxiogenic effect was evident in mice treated with shHcn4 compared to control littermates. Our findings suggest that HCN4 specifically contributes to anxiety-like behaviors in mice.
| INTRODUCTION
Ion channels are the molecular basis of fast signal generation and propagation in neurons. One ion channel family uniquely contributing to neuronal signaling is the hyperpolarization-activated and cyclic nucleotidegated (HCN) channels. In contrast to typical voltage-gated channels, HCN channels are not activated by membrane depolarization but by membrane hyperpolarization, and their activation kinetics can be modulated by direct binding of cyclic nucleotides. 1 Four homologous genes (hcn1-4) encoding isoforms of the HCN channel-forming subunits have been identified in mammals. [2] [3] [4] These HCN isoforms (HCN1-4) display distinct biophysical characteristics and can arrange as homotetrameric and as heterotetrameric channels, 5 giving rise to a variety of functional, biophysically diverse HCN channels. In addition to these pore-forming subunits, auxiliary subunits such as the tetratricopeptide repeatcontaining Rab8b-interacting protein (TRIP8b) modulate trafficking, targeting and gating of HCN channels. [6] [7] [8] Additionally, HCN channel kinetics are modulated by numerous factors such as cyclic nucleotides, phosphorylation and interacting proteins. 1 In neuronal tissue, HCN channels mediate the hyperpolarizationactivated (I h ) current, which was initially identified in pyramidal neurons of the hippocampal cornu ammonis1 (CA1) subfield. 9, 10 The I h current is essential for controlling rhythmic activity in neuronal circuits (eg, in the thalamocortical system during the sleep-wake cycle) and also affects several essential constituents of neuronal processing such as resting membrane potentials, dendritic integration and synaptic transmission. 11 Studies at the mRNA and protein level showed that the four HCN isoforms display distinct expression patterns in the nervous system. [12] [13] [14] Especially, notable was a pronounced HCN1 and HCN2 expression gradient along apical dendrites of CA1 pyramidal neurons, increasing from proximal to distal. This gradient has been shown to substantially affect integration and temporal adjustment of synaptic inputs to CA1 pyramidal neurons. [15] [16] [17] [18] Due to their diverging biophysical characteristics, HCN channels are likely candidates for directed modulation of hippocampal processing, as the individual isoforms differ strongly in for example, voltage dependence, activation kinetics and modulation by direct binding of cyclic nucleotides. 1 Notably, disruption of the I h current by transgenic manipulation of HCN1, HCN2 or TRIP8b affects hippocampus-based behaviors including depression and anxiety. [19] [20] [21] [22] However, so far only the functional contribution of HCN1 and HCN2 to hippocampal processing has been described, [22] [23] [24] while a potential role of HCN3 or HCN4 has not yet been addressed.
Notably, the biophysical characteristics of HCN4 differ strongly from other isoforms, with the most hyperpolarized midpoint of activation, the slowest activation kinetics and the most substantial cAMPinduced shift of activation toward depolarized potentials. 25 Transgenic mouse lines with impaired HCN4 expression have been used to show the importance of HCN4 in the context of cardiac pacemaking. [26] [27] [28] [29] However, reports on HCN4 expression in the murine hippocampus are scarce and not entirely consistent, 14, 30 and the effect of HCN4 disruption on hippocampal function has not been fully examined.
Here, we assessed the contribution of HCN4 to neuronal processing and hippocampus-based behaviors in mice. We examined the distribution of HCN4 using immunohistochemistry (IHC) and found that expression patterns of HCN4 largely resembled that of HCN1, but distinct differences were apparent at the subcellular level. For specific modulation of HCN4 expression, recombinant adeno-associated viral (rAAV) vectors mediating expression of short hairpin RNA against hcn4 (shHcn4) were injected into the dorsal hippocampus of mice.
Treatment with shHcn4 led to a reduction of hcn4 transcript expression by about 60% compared to control-injected mice as well as a decrease of HCN4 protein expression. HCN4 knockdown produced no effect on contextual fear conditioning (FC) or spatial memory.
However, a pronounced anxiogenic effect was evident in mice treated with shHcn4 compared to control littermates. In summary, HCN4 differs clearly from other HCN isoforms in its expression patterns as well as in its contribution to hippocampus-based behaviors.
| MATERIALS AND METHODS

| Antibodies
Primary and secondary antibodies used for IHC and western blot (WB) analysis are listed in the Supplementary Material (Table S1 ).
| Immunohistochemistry
Briefly, mice were transcardially perfused with ice-cold phosphate-buffered saline (PBS) followed by paraformaldehyde (PFA; 4% [w/v] were applied at 4 C for 3 days, and secondary antibodies were applied at room temperature for 4 hours (see Table S1 ). Fluorescent images were obtained with an inverted confocal microscope (TCS SP5II, Leica, Wetzlar, Germany) and analyzed using ImageJ software (ImageJ 1.46r, Wayne Rasband, US National Institutes of Health, Bethesda, Maryland).
| Constructs and rAAV preparation
Sequences containing the human U6 (hU6) promoter and shRNA constructs targeting the hcn4 mRNA were purchased from Sigma-Aldrich (Taufkirchen, Germany Viral particles were enriched by density gradient centrifugation.
The rAAV suspension was sublayered with iodixanol solutions (15%, 25%, 40% and 60% iodixanol; Sigma-Aldrich) and centrifuged (264,000 g, 4 C, 2 hours). Viral particles were collected in the 40% iodixanol phase and further purified using Amicon Ultra Centrifugal Filters (Ultracel-100 k, 15 mL; Merck Millipore). For determination of genomic titers, viral genomes were isolated using the DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany), and quantitative polymerase chain reaction (qPCR) was performed using primers framing a segment of the eGFP-encoding sequence (Table S2 ). Genomic titers were adjusted to 1 × 10 10 genome copies per ml. Lysis Reagent using a stainless steel bead in a TissueLyser II (Qiagen).
| Animals and stereotaxic injection
Proteins were removed using Phase Lock Gel tubes (5 Prime; QuantaBio, Beverly, Massachusetts) supplemented with 140-μL chloroform.
RNA was isolated using the RNeasy Mini Kit (Qiagen). RNA samples were split for two independent first-strand cDNA syntheses using the RETROscript Kit (Ambion/Thermo Fisher Scientific).
Thermocycling was performed in a LightCycler 1.5 (Roche, Mannheim, Germany) using the QuantiTect SYBR Green polymerase chain reaction (PCR) Kit (Qiagen). Gene-specific primers (Table S2) were designed in silico and synthesized by MWG Operon (Ebersberg, Germany). Specificity and efficiency of primers was confirmed via BLAST analysis and semiquantitative PCR on hippocampal cDNA. In order to check for genomic impurities, gapdh primers were designed to bind in exons separated by an intron of 134 bp. qPCR reactions were performed on first-strand cDNA samples in a total volume of 20 μL.
Results were analyzed using the C t method. Gene expression levels were normalized to the housekeeping gene gapdh.
| Quantification of protein expression by WB analysis
Total protein was isolated from dorsal hippocampal tissue after 3 to Table S1 ). Immunoreactive protein bands were detected using a Chemiluminescence Detection Kit for HRP 
| Behavioral paradigms
The contribution of HCN4 to hippocampus-dependent behavioral paradigms was assessed using three groups of mice. Behavioral tests proceeded from the least to the most stressful test for the animals ( Figure S1 ). Data from different groups were combined for statistical analysis. Behavioral testing and tissue collection were performed during the light phase.
| Elevated zero maze test
Naïve pair-housed mice were exposed to a Plexiglas elevated zero software. 33 For analysis, quadrants were defined as center (greater than 5 cm from arena wall) and peripheral (within 5 cm of arena wall) zones. Additionally, light beam crossings were recorded for locomotor activity (horizontal crossings) and rearing (vertical crossings).
| Statistical analysis
All data are given as mean ± SEM (SE of the mean 3 | RESULTS
| Expression of HCN4 in hippocampal tissue
All four HCN isoforms are expressed in the murine central nervous system (CNS), but their precise distribution has been shown to differ distinctly depending on the examined CNS region. 11 Generally, HCN1
and HCN2 are the predominantly expressed isoforms, and their function in neuronal signaling has been studied in detail, whereas little is known about the roles of HCN3 and HCN4. Here, we focused on the specific contribution of HCN4 to hippocampus-based behaviors. In a first step, expression profiles of all four HCN isoforms were examined in hippocampal tissue on the RNA and protein level.
Specific primers were used to amplify defined fragments of individual hcn isoforms (Table S2 ). Specificity and efficiency of these primer pairs was confirmed by BLAST analysis and semiquantitative PCR on mouse brain cDNA ( Figure S2 ). Transcript expression levels of hcn genes in murine hippocampal tissue were quantified by qPCR and normalized to gapdh. As shown in Figure 1A , the amount of hcn4 transcripts was much lower than that of hcn1 and hcn2 ( Figure 1A ), while hcn3 transcripts were barely detectable (not shown). Protein expression of HCN isoforms was examined on WBs ( Figure 1B ). WB results largely confirmed qPCR data, with strong expression of HCN1 and HCN2 and much lower expression of HCN4. Expression of HCN3
could not be detected on WBs (data not shown).
Using immunohistochemical (IHC) staining on hippocampal tissue sections with HCN isoform-specific primary antibodies, the cellular localization of HCN isoforms was examined. Several monoclonal and polyclonal antibodies were applied for labeling of individual isoforms (Table S1 ). Expression of HCN1, HCN2 and HCN4 was confirmed throughout the hippocampal formation ( Figure 1 , C1-C4). As already indicated by qPCR and western blotting, HCN4 protein expression was lower than that of HCN1 and HCN2, but distinct HCN4 expression patterns could be detected throughout the hippocampus along the dorsoventral axis ( Figure S3A ). Notably, we observed an expression gradient of HCN4 along the dendrites of CA1 pyramidal neurons ( Figure 1C4 ), a pattern which has previously only been reported for the HCN1 and HCN2 isoforms. 16, 17 We also identified additional distribution patterns for the individ- Higher magnification of coimmunostained sections showed that most HCN4-positive structures were also stained by HCN1-specific antibodies ( Figure 1G) . Notably, the presence of different HCN isoforms might indicate the possibility of the formation of heterotetrameric channels in these subcellular structures, which remains to be assessed in forthcoming studies. In addition to costained structures, we detected an even higher number of punctae that contained HCN1
but not HCN4 ( Figure 1G ).
In order to assess the subcellular localization of HCN1 and HCN4,
we performed a series of IHC stainings with antibodies specific for the individual HCN isoforms and for molecular markers of synaptic substructures ( Figure S3 
| Specific knockdown of HCN4 in dorsal hippocampus
Based on our IHC results, we hypothesized that HCN1 and HCN4 might contribute to similar hippocampus-dependent behavioral processes. While transgenic approaches allow comprehensive analysis of protein function in physiological contexts, transgenic manipulation of HCN4 is problematic as it can lead to embryonic lethality due to cardiac dysfunction. [26] [27] [28] [29] Previously, a lentivirus-based approach showed that knockdown of hcn1 restricted to the dorsal hippocampal CA1 region in rats resulted in antidepressant and anxiolytic-like behaviors. 19 Thus, we applied rAAV vectors by stereotaxic injection, to express HCN4-specific short hairpin RNAs (shRNA) in the dorsal hippocampus of mice to gain insight into a possible contribution of HCN4 channels to mouse behavior ( Figure 2A ). GÜNTHER ET AL.
P < 0.001). We did not observe an effect on hcn1 or hcn2 transcript levels ( Figure S4A ).
Western blotting was used to examine HCN4 knockdown efficiency at the protein level. Total protein was isolated from dorsal hippocampal tissue of mice injected with rAAV-shHcn4 or with control (rAAV-eGFP control vector or vehicle PBS). Two bands were detected with an HCN4-specific antibody ( Figure 3B ), corresponding to glycosylated and nonglycosylated HCN4 protein. 34, [37] [38] [39] Compared to control samples, the intensity of these bands was reduced in rAAV-shHcn4-treated samples ( Figure 3B ). Consistent with qPCR results, application of rAAVshHcn4 did not affect HCN1 or HCN2 protein expression levels ( Figure S4B ). Notably, no eGFP expression was detected in ventral hippocampal tissue isolated from the same animals ( Figure S4C ).
For IHC analysis, sections of tissue unilaterally injected with rAAV-shHcn4 and contralaterally injected with PBS were stained using HCN4-specific antibodies. eGFP autofluorescence confirmed injection and transduction of dorsal hippocampal tissue with rAAV.
No eGFP fluorescence was detected in the PBS-injected contralateral hippocampus. Expression of HCN4 was clearly reduced in shHcn4-treated regions compared to control tissue ( Figure 3C ).
In order to assess possible adverse or inflammatory responses to treatment with shRNA-encoding rAAV, we monitored expression of ). (C-G) Immunohistochemical analysis of saggital sections is shown for HCN1 (blue), HCN2 (green) and HCN4 (red). Proteins were stained with specific primary antibodies and fluorescently labeled secondary antibodies (see Table S1 ). Samples were examined by confocal microscopy. An overview of the hippocampus is shown on the left (C1-C4). Positions of higher magnification images are indicated by white frames, depicting the CA1 region (D1-D4), the CA3 region (E1-E4) and the DG (F1-F4) . High magnification of HCN1 and HCN4 staining in the CA3 region is shown in (G). Arrows indicate HCN1-positive structures, arrowheads indicate structures positive for both HCN1 and HCN4. Bars specify 50 μm glial fibrillary acidic protein (GFAP) as a marker for astrogliosis and activated caspase-3 (Casp-3) as a marker for apoptosis. 40 No increased expression of GFAP or Casp-3 was apparent in immunohistochemically stained tissue sections ( Figure S5A ) or on WBs ( Figure S5B ), when comparing shHcn4-treated tissue to control tissue.
In summary, these results confirm specific knockdown of the HCN4 isoform on the RNA and protein level, induced by a single infusion of rAAV-shHcn4 and restricted to the dorsal hippocampal region.
We did not observe off-target effects on gene expression of either homologous HCN isoforms or on markers for inflammatory tissue responses.
| Knockdown of HCN4 did not alter locomotor activity
In order to assess the contribution of HCN4 to mouse behavior, animals were bilaterally injected with rAAV and tested in several behavioral paradigms (see Figure S1 ). 
| Anxiogenic effect of HCN4 knockdown in the dorsal hippocampus
Previous studies have addressed the effects of I h current disruption on anxiety-related behaviors, but the results of these studies were not entirely consistent. 19, 20, 22 Thus, in this study, we examined whether HCN4 knockdown affects anxiety in mice.
Mice treated with rAAV-shHcn4 or control virions were tested in the EZM to assess anxiety levels ( Subsequently, the OFT was applied to examine whether this anxiogenic effect of HCN4 knockdown in the EZM was consistent in other anxiety-related paradigms ( Figure 5, S7) . The arena is also schematically depicted in Figure 5A . Notably, the observed anxiogenic effect persisted in the OFT, with shHcn4-treated animals spending significantly more time at the periphery of the open field arena compared to control mice ( Figure 5E ; t[28] = 3.2, P < 0.004). Overall ambulation was unaffected by HCN4 knockdown (Figure 5F ).
| No effect of HCN4 knockdown on spatial memory or fear memory
In order to determine whether HCN4 knockdown affects other hippocampus-based behaviors, we assessed spatial memory as well as contextual fear memory in shHcn4-treated mice and control litter-
mates. Spatial memory was tested using an SORtask. No significant difference of object exploration time for displaced and nondisplaced objects was observed when comparing mice treated with rAAVshHcn4 or with rAAV-eGFP control ( Figure S8 ).
Contextual fear memory was assessed using contextual FC. No significant difference of freezing levels was detected for shHcn4-treated mice compared to eGFP-treated littermates before or after applying a footshock of 0.75 mA ( Figure S9A ) or 1.5 mA ( Figure S9B ) for 2 seconds. We also tested the same animals in different paradigms of fear extinction and retrieval, but no significant differences were apparent between groups ( Figure S9 ). However, rAAVshHcn4-treated mice reliably showed slightly higher freezing levels than control-treated littermates during the 24-hour test as well as lower freezing levels during extinction, although this result did not reach statistical significance ( Figure S9 ).
Taken together, the results of this study showed a specific and reproducible anxiogenic effect of HCN4 knockdown in the dorsal hippocampus, without affecting other hippocampus-based behaviors.
| DISCUSSION
The HCN-mediated I h current modulates cellular membrane properties and plays an essential role in hippocampal signal processing. 11 Here, we specifically addressed the contribution of the HCN isoform 4 to hippocampus-based behaviors. Using IHC, we observed distribution patterns of HCN4 in the hippocampal formation that partially overlapped with those of HCN1 and HCN2. However, HCN4 expression levels were consistently lower compared to these two isoforms in hippocampal neurons. Overlapping expression between HCN4 and neurons, similar to the previously described gradient for the HCN1 and HCN2 isoforms. 15, 18 These expression gradients of HCN isoforms are physiologically reflected as a 6-fold increase of I h current densities from the soma to the distal dendrite. These current density profiles affect integration and temporal adjustment of synaptic inputs in CA1 pyramidal neurons. 16, 17 An essential aspect of HCN channel physiology is the distinct bio- In order to gain insight on the functional contribution of HCN4 to hippocampus-based behavioral processes, we applied a virus-based shRNA-mediated gene knockdown approach. Due to the crucial role of HCN4 in cardiac pacemaking during embryonic development, conventional transgenic approaches for disruption of the hcn4 gene can result in lethality in utero. [27] [28] [29] Notably, even in adult animals, HCN4
retains an important role in the maintenance of normal heart rhythmicity. 26 Therefore, we used stereotaxic injection of rAAVs to induce have been reported to display antidepressant-like behaviors but unchanged anxiety-related behaviors. 20, 22 Conversely, region-specific knockdown of HCN1 in the dorsal CA1 region of rats was shown to lead to both anxiolytic as well as antidepressant behaviors. 19 Therefore, the results of our study indicate that HCN4 might play an opposing role to HCN1 in anxiety-related behaviors.
Due to their high sensitivity toward cyclic nucleotides, HCN4 channels might also play a particular role in cAMP-modulated signal relay cascades, which are essential during hippocampal processing. In the presence of cAMP, the midpoint of activation shifts by up to 25 mV toward more depolarized potentials. 53, 55 Especially, the strong effect of TRIP8b on neuronal activity and behaviors in the thalamus 53, 55 suggests a direct functional effect of TRIP8b and HCN4 favored by the strong expression of HCN4 in thalamic tissue. Thus, TRIP8b might be essential for differentially modulating the functional contribution of individual HCN isoforms in hippocampal processing.
While the effect of I h current disruption on spatial memory is conversely discussed, studies agree that disruption of HCN1, HCN2 or TRIP8b does not affect contextual FC. 20, 22 In our study, knockdown of HCN4 in the dorsal hippocampus had no effect on overall performance in SOR tasks as well as in behavioral paradigms assessing contextual fear memory and fear extinction. Therefore, HCN4 does not appear to be a critical component for hippocampus-based memory processes. Our results strongly emphasize a specific role of HCN4 in anxiety-related behaviors.
Our findings of low HCN4 expression in several areas of the hippocampus, partially overlapping with the predominant HCN1 and HCN2 isoforms, supports the hypothesis of HCN4 not being a main constituent of hippocampal I h currents. Nevertheless, due to its distinct biophysical properties, the HCN4 isoform could serve to diversify native I h currents by forming heterotetrameric channels in hippocampal cells, possibly even in an activity-dependent manner. An essential aspect of future studies will be the dissection of subregionspecific effects of HCN channels modulating hippocampal processes.
Using virus-mediated RNAi-based approaches for simultaneous knockdown of HCN isoforms will allow electrophysiological and behavioral dissection of the specific contribution of individual HCN isoforms to hippocampal processes. All in all, the findings of this study
give additional insight into the molecular mechanisms underlying the dynamic regulation of anxiety-related behaviors. Especially, the contrast between the findings for HCN4 in this study and the reported results for HCN1 in the context of anxiety-related behaviors suggest HCN4 as a potential therapeutic target for treating anxiety. 
